JP2008521884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008521884A5 JP2008521884A5 JP2007544016A JP2007544016A JP2008521884A5 JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5 JP 2007544016 A JP2007544016 A JP 2007544016A JP 2007544016 A JP2007544016 A JP 2007544016A JP 2008521884 A5 JP2008521884 A5 JP 2008521884A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- composition
- ceftriaxone
- sulbactam
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2411/DEL/2004 | 2004-12-02 | ||
| IN2411DE2004 | 2004-12-02 | ||
| PCT/IN2005/000382 WO2006059344A1 (en) | 2004-12-02 | 2005-11-28 | Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008521884A JP2008521884A (ja) | 2008-06-26 |
| JP2008521884A5 true JP2008521884A5 (enExample) | 2008-12-18 |
| JP5269415B2 JP5269415B2 (ja) | 2013-08-21 |
Family
ID=35789266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007544016A Expired - Fee Related JP5269415B2 (ja) | 2004-12-02 | 2005-11-28 | 注射に有用なβ−ラクタマーゼ阻害剤を使用したβ−ラクタマーゼ媒介性の抗生物質耐性を抑制する組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8273732B2 (enExample) |
| EP (1) | EP1841432B1 (enExample) |
| JP (1) | JP5269415B2 (enExample) |
| KR (2) | KR20070067189A (enExample) |
| CN (1) | CN101060846A (enExample) |
| AT (1) | ATE476981T1 (enExample) |
| AU (1) | AU2005310888B2 (enExample) |
| BR (1) | BRPI0517128A (enExample) |
| CY (1) | CY1110886T1 (enExample) |
| DE (1) | DE602005022939D1 (enExample) |
| DK (1) | DK1841432T3 (enExample) |
| ES (1) | ES2349301T3 (enExample) |
| HR (1) | HRP20100591T1 (enExample) |
| MX (1) | MX2007006540A (enExample) |
| NZ (1) | NZ555075A (enExample) |
| PL (1) | PL1841432T3 (enExample) |
| PT (1) | PT1841432E (enExample) |
| RS (1) | RS51506B (enExample) |
| RU (1) | RU2397768C2 (enExample) |
| SI (1) | SI1841432T1 (enExample) |
| UA (1) | UA91204C2 (enExample) |
| WO (1) | WO2006059344A1 (enExample) |
| ZA (1) | ZA200704394B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030010176A (ko) * | 2001-07-25 | 2003-02-05 | 이병두 | 은행 열매 추출물과 호도 열매 추출물을 이용한 천식 치료제 |
| CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
| CN101129381B (zh) * | 2006-08-25 | 2012-02-01 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 |
| JP5639471B2 (ja) * | 2008-07-28 | 2014-12-10 | 惠三 山口 | 感染症治療効果増強剤 |
| CN101537009B (zh) * | 2009-04-30 | 2010-09-15 | 海口奇力制药股份有限公司 | 注射用头孢曲松钠他唑巴坦钠复方制剂的生产工艺 |
| JP2012176899A (ja) * | 2009-05-19 | 2012-09-13 | Mitsubishi Tanabe Pharma Corp | ２−（１−ピペラジニル）−５−メチルベンゼンスルホン酸誘導体を含む注射用水溶液 |
| PL2714034T3 (pl) * | 2011-05-28 | 2018-12-31 | Wockhardt Limited | Kompozycje zawierające cefepim i tazobaktam |
| MX362683B (es) * | 2011-07-26 | 2019-01-31 | Wockhardt Ltd | Composiciones farmacéuticas que comprenden antibiótico de beta-lactama, sulbactama e inhibidor de beta-lactamasa. |
| WO2013042140A2 (en) * | 2011-09-23 | 2013-03-28 | Manu Chaudhary | Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement |
| BR112014023402B1 (pt) | 2012-03-26 | 2020-09-29 | Santen Pharmaceutical Co., Ltd | Solução oftálmica compreendendo diquafosol e métodos para produção da mesma, para inibição da formação dos precipitados insolúveis na mesma, para redução da irritação ocular causada pela mesma e para aumentar a eficácia de conservação da mesma |
| MX365321B (es) | 2012-06-07 | 2019-05-29 | Los Angeles Childrens Hospital | Métodos para el tratamiento de neutropenia mediante agonistas retinoides. |
| WO2014052799A1 (en) * | 2012-09-27 | 2014-04-03 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine antibiotic compositions |
| AU2015219038B2 (en) | 2014-02-18 | 2018-10-18 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
| EP3125887A1 (en) * | 2014-03-29 | 2017-02-08 | Wockhardt Limited | Pharmaceutical compositions comprising cefepime or sulbactam |
| CA2914314C (en) * | 2014-04-03 | 2021-05-18 | Baxter International Incorporated | Injection bag and injection preparation assembly |
| US10201518B2 (en) | 2016-09-28 | 2019-02-12 | The University Of Hong Kong | Bismuth(III) compounds and methods thereof |
| US10668079B2 (en) | 2016-11-02 | 2020-06-02 | Xiangbei Welman Pharmaceutical Co., Ltd. | Composition composed of ceftriaxone sodium and sulbactum sodium |
| CN111249284B (zh) * | 2016-11-03 | 2022-10-04 | 湘北威尔曼制药股份有限公司 | 治疗淋病奈瑟菌感染的头孢曲松钠舒巴坦钠 |
| RU2665006C1 (ru) * | 2017-02-28 | 2018-08-24 | Общество с ограниченной ответственностью "Супербаг Солюшенс" | Композиция антимикробных препаратов для лечения инфекционных заболеваний людей и животных и способ её применения |
| KR102790878B1 (ko) | 2018-08-09 | 2025-04-02 | 앤타바이오 에스에이에스 | 세린 베타-락타마제의 억제제로서 다이아자바이사이클로옥타논 |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| KR20230121863A (ko) | 2020-12-17 | 2023-08-21 | 아이덱스 래보러토리즈, 인코포레이티드 | 로키산 홍반열 검출 및 치료 |
| WO2025165952A1 (en) * | 2024-01-31 | 2025-08-07 | The Penn State Research Foundation | Process for reduction of drug-resistant bacteria |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630510B1 (en) * | 1999-10-28 | 2003-10-07 | Merck & Co., Inc. | Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections |
| US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
| ES2298672T3 (es) * | 2003-04-14 | 2008-05-16 | Wyeth Holdings Corporation | Composiciones que contienen piperacilina y tazobactam utiles para inyeccion. |
-
2005
- 2005-11-28 DE DE602005022939T patent/DE602005022939D1/de not_active Expired - Lifetime
- 2005-11-28 AT AT05817957T patent/ATE476981T1/de active
- 2005-11-28 KR KR1020077010375A patent/KR20070067189A/ko not_active Ceased
- 2005-11-28 BR BRPI0517128-8A patent/BRPI0517128A/pt not_active IP Right Cessation
- 2005-11-28 MX MX2007006540A patent/MX2007006540A/es active IP Right Grant
- 2005-11-28 ES ES05817957T patent/ES2349301T3/es not_active Expired - Lifetime
- 2005-11-28 EP EP05817957A patent/EP1841432B1/en not_active Expired - Lifetime
- 2005-11-28 HR HR20100591T patent/HRP20100591T1/hr unknown
- 2005-11-28 NZ NZ555075A patent/NZ555075A/en not_active IP Right Cessation
- 2005-11-28 WO PCT/IN2005/000382 patent/WO2006059344A1/en not_active Ceased
- 2005-11-28 DK DK05817957.3T patent/DK1841432T3/da active
- 2005-11-28 PT PT05817957T patent/PT1841432E/pt unknown
- 2005-11-28 PL PL05817957T patent/PL1841432T3/pl unknown
- 2005-11-28 SI SI200531130T patent/SI1841432T1/sl unknown
- 2005-11-28 RS RSP-2010/0465A patent/RS51506B/sr unknown
- 2005-11-28 KR KR1020097018388A patent/KR101244362B1/ko not_active Expired - Fee Related
- 2005-11-28 JP JP2007544016A patent/JP5269415B2/ja not_active Expired - Fee Related
- 2005-11-28 UA UAA200707280A patent/UA91204C2/ru unknown
- 2005-11-28 US US11/720,710 patent/US8273732B2/en not_active Expired - Fee Related
- 2005-11-28 AU AU2005310888A patent/AU2005310888B2/en not_active Ceased
- 2005-11-28 RU RU2007124325/15A patent/RU2397768C2/ru not_active IP Right Cessation
- 2005-11-28 CN CNA2005800395645A patent/CN101060846A/zh active Pending
-
2007
- 2007-05-29 ZA ZA200704394A patent/ZA200704394B/xx unknown
-
2010
- 2010-11-10 CY CY20101101012T patent/CY1110886T1/el unknown
-
2012
- 2012-09-25 US US13/626,236 patent/US9012442B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008530082A5 (enExample) | ||
| TWI342212B (en) | Liquid pharmaceutical formulations of palonosetron | |
| US6028222A (en) | Stable liquid paracetamol compositions, and method for preparing same | |
| RU2007124325A (ru) | Композиции для преодоления опосредованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенные для инъекции | |
| CN1289084C (zh) | 药物制剂 | |
| JP6745798B2 (ja) | パラセタモール及びイブプロフェンを含む水性配合物 | |
| CN1396828A (zh) | 含有培美西德以及一硫代甘油l－半胱氨酸或巯乙酸的药物组合物 | |
| BRPI0612447A2 (pt) | composição antibiótica de dose fixa, processo para a preparação de um produto de combinação antibiótica de dose fixa, processo para a preparação de uma injeção lìquida e usos de pó seco para injeção e injeção lìquida | |
| EP2588097B1 (en) | Pharmaceutical compositions comprising paracetamol and process for preparing the same | |
| US9125905B2 (en) | Liquid pharmaceutical formulations of palonosetron | |
| JP7777518B2 (ja) | リファブチンの処置方法、使用および組成物 | |
| JP5203191B2 (ja) | エンド−ｎ−（９−メチル−９−アザビシクロ［３．３．１］ノン−３−イル）−１−メチル−１ｈ−インダゾール−３−カルボキサミド塩酸塩の医薬製剤 | |
| CN114306218B (zh) | 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物 | |
| WO2009081283A2 (en) | Aqueous formulations of acetaminophen for injection | |
| JP5811404B2 (ja) | セトロンを頬側経粘膜投与するための処方物（ｆｏｒｍｕｌａｔｉｏｎ） | |
| JP2018048096A (ja) | 液体製剤、及び、パロノセトロンの安定性を向上する方法 | |
| KR101169478B1 (ko) | 용액 의약조성물 | |
| WO2014062568A2 (en) | Amoxicillin formulation and method of using such formulation | |
| WO2014083071A1 (en) | Injectable liquid formulation of the combination of tramadol and paracetamol | |
| JPWO2009075309A1 (ja) | 製剤組成物 | |
| WO2024151603A1 (en) | Hydromorphone formulations for multi-dose products | |
| US20250319066A1 (en) | Injectable dmt formulations | |
| WO2007069070A2 (en) | Aseptically filled multidose injectable dosage forms of granisetron |